Karyopharm Therapeutics
KPTI
KPTI
106 hedge funds and large institutions have $563M invested in Karyopharm Therapeutics in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 25 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
+3
Holders Change %
+2.91%
% of All Funds
2.33%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
24
Increased
40
Reduced
25
Closed
21
Calls
$3.67M
Puts
$3.78M
Net Calls
-$117K
Net Calls Change
-$3.89M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$58.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$19.5M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.4M |
| 4 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$12.2M |
| 5 |
Millennium Management
New York
|
+$11.7M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$25.8M |
| 2 |
O
OrbiMed
New York
|
-$20M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15.6M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$8.41M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$4.04M |
